CD19 compositions and methods for immunotherapy

Biocircuit systems with stimulus-responsive effector modules address the limitations of current cancer immunotherapy by regulating immunotherapeutic agents, improving anti-tumor responses and reducing toxicity.

AU2023214349C1Pending Publication Date: 2026-07-23OBSIDIAN THERAPEUTICS INC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
AU2023214349
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-08-11
Publication Date
2026-07-23
Estimated Expiration
2038-03-02

Smart Images

  • Figure 00000259_0000
    Figure 00000259_0000
  • Figure 00000260_0000
    Figure 00000260_0000
  • Figure 00000260_0001
    Figure 00000260_0001
Patent Text Reader

Abstract

2023214349 11 Aug 2023
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Methods for regulating protein function in cells in vivo using synthetic small molecules

    US20140010791A1